PPARG and steatosis: GW9662 alleviated ethanol-stimulated hepatocyte steatosis through inhibiting PPARγ pathway, so YCHT also should exert its anti-ethanol-stimulated hepatocyte steatosis efficacy through PPARγ pathway.